Skip to main content
. 2020 Jun 5;5(2):172–182. doi: 10.1089/can.2019.0051

Table 5.

Reported Use of Required and Recommended Practices Among Washington State Health Care Professionals with a History of Providing a Medical Cannabis Authorization

  Percentage of respondents
Total respondents (N)
Always or very often (%) Often or sometimes (%) Rarely or never (%)
Required practices
 Advised a patient about the risks and benefits of medical use of cannabis 89.5 7.0 3.5 57
 Complete an in-person physical examination 89.5 7.0 3.5 57
 Document measures other than cannabis used to treat the terminal or debilitating medical condition 89.5 7.0 3.5 57
 Complete an in-person physical examination at least annually to renew an adult's authorization 87.7 7.0 5.3 57
 Document the terminal or debilitating medical condition in patient's medical record 87.7 5.3 7.0 57
 Documented relationship as principal care provider for the patient's terminal or debilitating medical condition 86.0 8.8 5.3 57
 Inform patient of other options for treatment 86.0 10.5 3.5 57
 Complete an authorization on form 84.2 1.8 14.0 57
 Discussed how to use cannabis 49.1 21.1 29.8 57
 Complete an in-person physical examination at least every 6 months to renew a minor's authorization 44.4 4.4 51.1 45
Recommended practices
 Performed mental health screen for problems such as depression and anxiety screening 53.6 32.1 14.3 56
 Performed screening for substance misuse 50.0 16.7 33.3 54
 Advised patient to seek advice on specific cannabis products from the retail store 49.1 40.0 10.9 55
 Discussed types of products the qualifying patient should seek from a retail outlet. 45.5 27.3 27.3 55
 Provided counseling to breastfeeding women about potential effects to a child 45.2 9.5 45.2 42
 Provided counseling about long term effects of cannabis on the developing brain 45.2 14.3 40.5 42
 Obtained urine or blood screening for substance misuse 22.9 18.8 58.3 48
 Performed a pregnancy test for a female 22.2 14.8 63.0 54
 Required a medical cannabis agreement similar to a controlled substance agreement 20.0 5.5 74.5 55